JAMESFETT
09-21-2007, 10:06 AM
Recent reports support certain tests for the diagnosis of cardiomyopathies:
1)Non invasive (for everyone):
a)Plasma biomarkers, such as CRP and Troponin
b)Cardiac Magnetic Resonance imaging with enhancement
2)Invasive (for those not improving to EF 40 % in first 2 to 4 months):
a)Endomyocardial biopsy
b)Immunohistochemistry on biopsy tissue
c)Polymerase chain reaction testing for virus on biopsy tissue
[see Schulz-Menger and associates: Integrated biomarkers in cardiomyopathies--a stepwise approach for diagnosis and treatment. Herz 2007;32:458-72.]
There is convincing evidence that supports current use of these diagnostic techniques for all new pregnancy-associated heart failure patients and new dilated cardiomyopathy patients.
AND:
"Pimobendan, FTY720 are promising agents for the treatment of viral myocarditis" [see Matsumori. Herz 2007;32:452-56.]
These newer treatments are still in research mode, but we are seeing progress.
JD
1)Non invasive (for everyone):
a)Plasma biomarkers, such as CRP and Troponin
b)Cardiac Magnetic Resonance imaging with enhancement
2)Invasive (for those not improving to EF 40 % in first 2 to 4 months):
a)Endomyocardial biopsy
b)Immunohistochemistry on biopsy tissue
c)Polymerase chain reaction testing for virus on biopsy tissue
[see Schulz-Menger and associates: Integrated biomarkers in cardiomyopathies--a stepwise approach for diagnosis and treatment. Herz 2007;32:458-72.]
There is convincing evidence that supports current use of these diagnostic techniques for all new pregnancy-associated heart failure patients and new dilated cardiomyopathy patients.
AND:
"Pimobendan, FTY720 are promising agents for the treatment of viral myocarditis" [see Matsumori. Herz 2007;32:452-56.]
These newer treatments are still in research mode, but we are seeing progress.
JD